Pharma, Biotech Licensing Alliances, Best Practices and Deals to Be Reviewed at Upcoming iiBIG (International Institute for Business Information & Growth LLC) San Diego Summit

PORT WASHINGTON, NY--(Marketwire - January 11, 2011) -

iiBIG presents the Pharma & Biotech Licensing & Partnering conference, scheduled for March 3-4, 2011 at the Doubletree Hotel San Diego Downtown in San Diego, CA.

This year’s forum will provide insight and guidance to pharmaceutical and biotechnology licensing, business development, and deal-making executives from across the world, and review issues that will help large and small pharmaceutical companies to structure the best deals, carefully monitor risks and, perhaps, find their next partner. The program is for pharmaceutical and biotechnology executives involved in licensing, business development, and strategic alliances and partnerships.

Speaking faculty includes executives from 3M Drug Delivery Systems; Adolor Corporation; Afraxis, Inc.; Altea Therapeutics Corporation; Aradigm Corporation; Arena Pharmaceuticals; Avalon Ventures; Centocor R&D, Inc.; Eisai Inc.; Elan Drug Technologies; Eurand; Exelixis; Halozyme Therapeutics, Inc.; Johnson & Johnson; Lilly Ventures; MacroGenics, Inc.; MannKind Corporation; Merck & Co.; NAEJA Pharmaceutical Inc.; Novartis Pharmaceuticals; Pfizer; Pfizer Venture Investments; Poniard Pharmaceuticals; Prosensa Therapeutics; Purdue Pharma; Ranbaxy Laboratories Limited; Santarus, Inc.; Shire Pharmaceuticals; Somnus Therapeutics, Inc.; Sun Pharmaceuticals; Supernus Pharmaceuticals, Inc.; TheraKine Limited; and ZS Associates.

Conference agenda will cover:

• Exploring alliances with nontraditional partners
• Gaining a competitive advantage through corporate venturing and innovation initiatives
• Examining the careful choices made when building a biotech company in today’s capital environment
• Developing innovative strategies for market, patient, and payer-friendly drug delivery products

Those who register by Monday, January 31, 2011 can save $200 on conference rates. For complete conference information: http://www.iibig.com/P1101

About iiBIG
iiBIG is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. We focus on the most pressing and timely issues facing decision-makers in today’s global economy. Our events provide learning and networking settings for some of the business community’s “BIGgest” thinkers -- those who occupy the highest levels in their companies and organizations. For more information, visit: http://www.iibig.com.